Back to search

Article

Costimulatory Molecule Expression Profile as a Biomarker to Predict Prognosis and Chemotherapy Response for Patients With Small-cell Lung Cancer

2021-08-30

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>: Small cell lung cancer (SCLC) is the deadliest pathological subtype of lung cancer with few precise treatment options. Owing to the paucity of specimens, progress in identifying prognostic and therapeutic biomarkers for SCLC has been stagnant for decades. Considering the costimulatory molecules are essential elements in modulating anti-tumor immune responses and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2ca70d3f-eb12-5c7b-b3f3-8014ed65d26b
DOI
10.21203/rs.3.rs-801123/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Costimulatory Molecule Expression Profile as a Biomarker to Predict Prognosis and Chemotherapy Response for Patients With Small-cell Lung CancerDOI 10.21203/rs.3.rs-801123/v1
Costimulatory molecule expression profile as a biomarker to predict prognosis and chemotherapy response for patients with small cell lung cancer.Semantic proximity
Identification of a costimulatory molecule-based signature for predicting prognosis risk and immunotherapy response in patients with lung adenocarcinomaSemantic proximity
An Immune-related Lncrna Signature Predicts Prognosis and Adjuvant Chemotherapeutic Response in Patients With Small-cell Lung CancerSemantic proximity
Identification of a Novel Costimulatory Molecule-Related Signature to Predict Prognostic Risk and Immunotherapy Response in Hepatocellular CarcinomaSemantic proximity
Integrative analysis of multi‐omics data reveals the heterogeneity and signatures of immune therapy for small cell lung cancerSemantic proximity
Construction of an immunogenic cell death related gene signature: A new prognostic model for small cell lung cancerSemantic proximity
Establishment and validation of an immune-associated signature in lung adenocarcinoma.Semantic proximity
Development and validation of a novel immune-related prognostic signature in lung squamous cell carcinoma patientsSemantic proximity
Identification of a prognostic immune-related signature for small cell lung cancer.Semantic proximity
A signature based on costimulatory molecules for the assessment of prognosis and immune characteristics in stomach adenocarcinomaSemantic proximity
Analysis of Clinical Implications and Immune Landscape in Prognostic Model based on Immune Cell Signatures for Lung Adenocarcinoma PatientsSemantic proximity
Identification of Immune Subtypes and Candidate mRNA Vaccine Antigens in Small Cell Lung CancerSemantic proximity
Select a neighboring publication to make it the new centre.